Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kedrion Fibrin Sealant for aerostasis in pulmonary resection
2007-005583-27Phase 2Completed
- Sponsor
- Kedrion Biopharma
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fibrin sealant in bronchial carcinoma and interstitial pneumonia (2 arms), sponsored by Kedrion Biopharma. Primary endpoint: Time to drain removal. Started Jun 2008; status: completed.
02
Drugs
fibrin sealant
03
Conditions
bronchial carcinomainterstitial pneumonia
Beyond the preview
Go deeper on 2007-005583-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005583-27.